HOME >> MEDICINE >> NEWS
Scientists stalk PPAR-gamma, find novel cancer connection

In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.

"To our knowledge, this is the first time anyone has shown that multiple myeloma cells are sensitive to these agents, and we found multiple myeloma cells are killed quite effectively," says lead author Richard P. Phipps, Ph.D., professor of Environmental Medicine and of Oncology at the University of Rochester Medical Center.

The research was reported in the November issue of Clinical Immunology.

The drugs in question are from the thiazolidinedione (TZD) class of anti-diabetic therapies, known as PPAR-gamma ligands. They bind to PPAR-gamma, a protein associated with multiple myeloma and many other cancers, as well as chronic inflammation and diabetes. When the drugs bind to PPAR-gamma, at least in laboratory experiments, the cancerous cells are destroyed.

PPAR-ligands are emerging as a new type of cancer therapy because they directly target errant cells and stop tumor growth, at least in animal models. Phipps' laboratory also found that the PPAR-ligands currently used in anti-diabetic drugs could induce a type of cell death called apoptosis. This is significant because multiple myeloma is very difficult to treat, as it is usually resistant to drug-induced apoptosis.

Another encouraging factor is that the anti-diabetes drugs were able to kill the multiple myeloma cells, despite the fact that myeloma produces its own growth factor (Interleukin 6), which usually enables the cancer to multiply more effectively. Furthermore, the Phipps lab found that the effectiveness of the TZD drugs was enhanced when combined with Vitamin A-like compounds.

Co-investigator Steven Bernstein, M.D., who treat
'"/>

Contact: Leslie Orr
leslie_orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
8-Dec-2004


Page: 1 2

Related medicine news :

1. Scientists replicate hepatitis C virus in laboratory
2. Scientists identify brain regions that decide where we look
3. Scientists uncover new mechanism for the amygdala in fear recognition
4. Scientists identify protein critical to melanoma growth
5. Scientists discover recipe for life: eating the Polymeal cuts heart disease by 76%
6. Scientists study fish oil diet in bid to cut heart attack risks
7. Scientists discover enzyme crucial to the transportation of proteins within cells
8. Scientists turn on the gender lens on cardiovascular disease research
9. Scientists align billion-year-old protein with embryonic heart defects
10. Scientists pinpoint flaw, offer new promise for stroke treatment
11. Scientists discover enzyme crucial to HIV replication

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2018)... , ... August 17, 2018 , ... ... today announced that it is introducing its new MedAttentive Solution at the ... offerings by delivering customized alerts and notices that follow patients through all points ...
(Date:8/17/2018)... ... August 17, 2018 , ... Inc. magazine today ... most prestigious ranking of the nation’s fastest-growing private companies. The list represents a ... segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, ...
(Date:8/17/2018)... ... August 17, 2018 , ... Charles E. Crutchfield III, ... patient, Haps, a sand tiger shark, to help with his scoliosis (abnormal curvature of ... well as in human care, can develop scoliosis. Some types of scoliosis are caused ...
(Date:8/15/2018)... ... August 15, 2018 , ... Today David Hyde Apparel ... , Born out of a desire for confidence and comfort year-round, the ... body odor – even in the hottest, most humid of climates. , The brainchild ...
(Date:8/15/2018)... ... August 15, 2018 , ... ... Psy.D., BCBA-D, to associate editor of Behavior Analysis in Practice, one of the ... the chief clinical standards and research officer for Trumpet, leading the company’s research ...
Breaking Medicine News(10 mins):
(Date:8/15/2018)... Pa. (PRWEB) , ... August 15, 2018 , ... ... Health officials today broke ground on a new full-service hospital in Pine ... to the residents of Pittsburgh’s northern suburbs. , Expected to open ...
(Date:8/15/2018)... ... , ... Help Your Diabetes (HYD) is a Patent Pending, Internationally known, Natural, ... their medication, working in conjunction with their primary physician. , The Founder/CEO, Dr. ... of "Imagine Living Without Type 2 Diabetes. Dr. Hockings has given over 240 diabetes ...
(Date:8/15/2018)... RAPIDS, Mich. (PRWEB) , ... August 15, 2018 ... ... an addition to their expansive lineup of casters. The newly designed Diamond ... of movement and stability. Manufactured with an antimicrobial compound injected into a ...
Breaking Medicine Technology:
Cached News: